Q2 2020 Holdings
Filed 2020-08-14 | 135 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $231.2M | 1,562,986 | 17.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $191.5M | 715,900 | 14.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $170.2M | 4,847,300 | 13.0% |
| Alector Inc(ALEC) | COM | 014442107 | $146.0M | 5,975,322 | 11.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $141.3M | 4,673,850 | 10.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $92.4M | 1,728,421 | 7.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $84.9M | 1,335,700 | 6.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $55.2M | 1,228,189 | 4.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $48.2M | 2,753,567 | 3.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $45.6M | 464,000 | 3.5% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $34.7M | 1,380,160 | 2.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $19.4M | 1,196,347 | 1.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $18.4M | 6,767,584 | 1.4% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $11.2M | 239,186 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.1M | 625,000 | 0.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $5.5M | 220,350 | 0.4% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $2.9M | 68,100 | 0.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $986.0K | 29,400 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $311.1K | 7,406,307 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $264.2K | 9,614,280 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $242.0K | 2,156,000 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $206.0K | 13,822,463 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $200.2K | 2,589,100 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $193.4K | 666,100 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $190.3K | 6,962,899 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $182.4K | 6,645,100 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $177.3K | 2,745,327 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $169.5K | 2,882,200 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $161.6K | 3,240,514 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $159.4K | 2,867,910 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $151.2K | 1,324,100 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $144.7K | 1,185,915 | 0.0% |
| Burning Rock Biotech LTD | SPONSORED ADS | 12233L107 | $128.2K | 4,746,071 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $108.7K | 280,300 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $106.3K | 3,426,325 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $98.6K | 2,921,967 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $91.8K | 226,400 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $89.7K | 559,649 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $82.5K | 439,700 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $79.8K | 4,004,442 | 0.0% |
| Imara Inc | COM | 45249V107 | $75.2K | 2,719,902 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $68.7K | 3,290,744 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $67.2K | 1,125,700 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $64.3K | 112,800 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $63.0K | 1,679,417 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $62.7K | 638,558 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $58.1K | 2,711,013 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $57.1K | 2,404,100 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $56.8K | 5,402,730 | 0.0% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $56.3K | 3,224,770 | 0.0% |